Are Analysts and Investors Getting Too Down on eBay?
As a result analysts piled on to the stock, but they may have been overly negative, considering the earnings report.
As a result analysts piled on to the stock, but they may have been overly negative, considering the earnings report.
24/7 Wall St. has highlighted a few of the important points of the Facebook quarterly report and reviewed what analysts were saying afterward.
After the announcement that its Phase 2 trial of Ruxolitinib would be stopped a few analysts took a deeper look at Incyte and realized that it might not be as bad as initially thought.
Seagate Technology reported better-than-expected fiscal second-quarter before the markets opened Friday.
Westlake Chemical announced that it submitted a proposal to acquire all outstanding shares of Axiall for $20 apiece, but the bid was rejected by the Axiall board.
The SEC announced on Friday that a Manhattan-based investment advisory firm and its Toronto-based hedge fund manager have agreed to settle charges that they misled investors.
MasterCard reported mixed fiscal first-quarter financial results after the markets closed Thursday.
AbbVie reported mixed fourth-quarter financial results after the markets closed Thursday.
Electronic Arts reported better-than-expected fiscal third-quarter financial results after the markets closed Thursday.
Visa reported mixed fiscal first-quarter financial results after the markets closed Thursday.
Amgen reported better-than-expected fourth-quarter financial results after the markets closed Thursday.
AbbVie is scheduled to report its fourth-quarter financial results before the markets open Friday.
More than 32 million OTG shares are expected to price in the range of $16 to $18 per share in an IPO valued at up to more than $672 million.
Microsoft is scheduled to report its fiscal second-quarter financial results after the markets close on Thursday.
Celgene reported mixed fourth-quarter financial results before the markets opened on Thursday.
Altria reported mixed fourth-quarter financial results before the markets opened on Thursday.
Under Armour reported better-than-expected fourth-quarter financial results before the markets opened on Thursday.
As of the January 15 settlement date, some of the latest short interest readings for major oil companies are backing off of highs, while others are attempting to push new highs.
The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Short interest increased in most of these selected biotech stocks for the most recent settlement date.